Skip to main content
OpenTrials
Completed

NCT Number: NCT02238912

Evaluation of Preclinical Toxicity andTherapeutic Efficacy of Kandhaga Rasayanam in Padarthamarai

this study is intended to find out the therapeutic efficacy of the siddha drug Kandhaga Rasayanam in Padarthamarai ( Ring worm infection )

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Tinea Infections Such as Tinea Corporis, Tinea Cruris, Tinea Pedis, Tinea Mannum, Tinea Barbae, Tinea Capitis Are Studied Bacterial Infections and Mycoses Dermatitis Dermatomycoses Foot Dermatoses Foot Diseases Infections Intertrigo Mycoses Pathological Conditions, Signs and Symptoms Pruritus Signs and Symptoms Skin Diseases Skin Diseases, Eczematous Skin Diseases, Infectious Skin Manifestations Skin and Connective Tissue Diseases Tinea Tinea Cruris Tinea Pedis tinea barbae

Age range

18 year–60 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2

Primary location

National institute of siddha

Chennai, Tamil Nadu, 600047, India

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients clinically diagnosed with tinea infection.
  • direct microscopy skin scraping test positive.

Exclusion criteria

  • pregnant or nursing women.
  • use of other topical or oral antifungals, immunosuppressive drugs, anthelmintic drugs either currently or during 2 weeks preceeding initiation of drug trial.
  • allergy or hyperensitivity to any component of the drug.
  • clinical case of eczema, lichen planus, pityriasis versicolor, drug induced eruptions, urticaria, intertrigo, tinea ungium.
  • diabetic patients.

Treatment and study plan

kandhaga rasayanam

Drug

KANDHAGA RASAYANAM is a siddha herbo mineral drug with sulphur as a sole mineral ingredient. It is chosen from the classic Siddha text Siddha Vaidhya Thirattu.

Other names: Siddha herbo mineral drug KR.

Primary outcomes

  1. skin scrapping test

    Time frame: 45 days

Secondary outcomes

  1. itching, quality of life

    Time frame: 45 days

Other outcomes

  1. burning sensation, vanishing of lesions

    Time frame: 45 days

Sponsors and collaborators

Lead sponsor

National institute of Siddha

Other Gov

Registry information

Official study title

Evaluation of Preclinical Toxicity of a Siddha Formulation Kandhaga Rasayanam ( KR ) and Its Therapeutic Efficacy in Padarthamarai ( Dermatophytoses ) by an Open Clinical Trial

Acronym: KR

Important dates

Study start
2012
Primary completion
2014
First posted
Sep 12, 2014
Registry last updated
Sep 12, 2014

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.